Allegheny Health Network’s Post

👉First day of #EULAR2024 🔸Join me today at the Clinical Abstracts Session: clinical aspects of SSc 📍Room A7 ⏰5 pm ➡️The role of inflammation in SSc: CRP-associated phenotypes and prognostic implications @EUSTAR_org @JOVREUM @EMEUNET @ReumaLeon

In a presentation at the Cardiogenic Shock Working Group Global Summit in 2023, Jaime Hernandez-Montfort, MD discusses "Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock." Watch the presentation here: https://lnkd.in/eWbvb5i3

Focus on a case report on MOBIDERM for fibrosis reduction. MOBIDERM FOR FIBROSIS REDUCTION: Use of a tissue mobilising compression system¹ Find out more about this case report (level of evidence: IV) now: https://ow.ly/TTc550ORGX8 Key takeaway: MOBIDERM bandages seem to help in reducing lymphostatic fibrosis and achieving further lymphedema volume reduction. If you have any questions about MOBIDERM, please reach out to our awesome clinical specialist Jenni Muscat ! (1) Pamela Hodgson, Marie-Eve Letellier, Katrin Schumann, Linda Henry — Journal of Lymphoedema (2011), Vol 6, No 2

A great way to start the new year. In this publication, we propose a nuanced, practical approach to the diagnosis and management of Essential Thrombocytosis in a resource-limited clinical setting. https://lnkd.in/dbj8ezfa

Heart failure poses a silent risk of thrombotic events, and is a condition that is under-recognised when it comes to its diagnosis, management and treatment in clinical settings. In this new piece on Lab Insights by Dr Niti Dawar and Yingli Huang, the unmet need is highlighted by the lack of clear guidelines and research. Read more to find out what gaps need to be addressed to improve this issue. https://lnkd.in/g9zeBcYY

https://lnkd.in/eevs9rzJ Discover the latest developments in Sarcoidosis therapy with our article, "Breakthroughs in Sarcoidosis Treatment: What You Required to Know. "Check out the reasons and signs and symptoms of Sarcoidosis, conventional treatment approaches, emerging therapies, and recurring scientific trials. Learn about way of life adjustments that can aid take care of Sarcoidosis and discover corresponding and alternative treatments. Dive into the future expectation of Sarcoidosis therapy, including encouraging advancements that are shaping the landscape of care for this condition. Keep notified and empowered on your trip towards much better wellness with this thorough guide to Sarcoidosis therapy choices.

43rd #ISICEM: The recordings from our symposium on "Hemoadsorption with CytoSorb® in critically ill patients - Best practice and key learnings" are available in our media center. 📺 Watch “Update on drug removal: More pros than cons”, presented by Dr. Konstanty Szuldrzynski 👉 https://lnkd.in/gnvGbtKq 📺 Watch “Good and bad cytokines in sepsis – Myths and facts”, presented by Prof. Peter Pickkers 👉 https://lnkd.in/gtwwjkFJ #CytoSorbents #Hemoadsorption #CytoSorb

💥The following paper: "Continuous Subcutaneous Apomorphine Infusion in Parkinson’s Disease: A Single-Center, Long-Term Follow-Up Study of the Causes for Discontinuation" is published in the Journal of Personalized Medicine MDPI at: https://lnkd.in/gnUHGS2u We invite you to read this paper at the above link. And also hope that you could consider JPM (https://lnkd.in/g3jxwN_H) when submitting your next paper. #personalizedmedicine #parkinsonsdisease

This webinar brings together experts discussing clinically relevant topics, for both female and male patients, such as ovarian reserve measurement, the management of azoospermia and challenges in ovarian stimulation. Register now 👉️ https://eur.cvent.me/aG3OP